Abstract
Background
We describe the demographic, clinical and laboratory findings along with the treatment and outcomes among children meeting the case definition of Pediatric Inflammatory Multisystem Syndrome — Temporally associated with SARS-CoV-2 (PIMS-TS).
Methods
We analyzed the clinical and laboratory findings of children who presented with PIMS-TS during an 8-week period from May 4, 2020 to July 8, 2020.
Results
We report 19 children with a median age of 6 year (IQR: 13 months-16 years), who met the case definition of PIMS-TS. All of them presented with fever. Multi organ involvement (79%), mucocutaneous involvement (74%), cardiovascular symptoms (63%) and gastrointestinal symptoms (42%) were the other features. Elevated levels of C-reactive protein was found in all of them and the majority of them had evidence of coagulopathy; intensive care admissions were needed in 12 (63%) and vasoactive medications were given to 6 (31.5%) children. There were no deaths.
Conclusion
Children with PIMS-TS present with a wide range of signs and symptoms. Fewer children in this series had coronary artery abnormalities, and there was a low incidence of RT-PCR positivity with high presence of SARS-CoV-2 antibodies.
We describe the demographic, clinical and laboratory findings along with the treatment and outcomes among children meeting the case definition of Pediatric Inflammatory Multisystem Syndrome — Temporally associated with SARS-CoV-2 (PIMS-TS).
Methods
We analyzed the clinical and laboratory findings of children who presented with PIMS-TS during an 8-week period from May 4, 2020 to July 8, 2020.
Results
We report 19 children with a median age of 6 year (IQR: 13 months-16 years), who met the case definition of PIMS-TS. All of them presented with fever. Multi organ involvement (79%), mucocutaneous involvement (74%), cardiovascular symptoms (63%) and gastrointestinal symptoms (42%) were the other features. Elevated levels of C-reactive protein was found in all of them and the majority of them had evidence of coagulopathy; intensive care admissions were needed in 12 (63%) and vasoactive medications were given to 6 (31.5%) children. There were no deaths.
Conclusion
Children with PIMS-TS present with a wide range of signs and symptoms. Fewer children in this series had coronary artery abnormalities, and there was a low incidence of RT-PCR positivity with high presence of SARS-CoV-2 antibodies.
| Original language | English |
|---|---|
| Pages (from-to) | 1010-1014 |
| Number of pages | 5 |
| Journal | Indian Pediatrics |
| Volume | 57 |
| Issue number | 11 |
| Early online date | 6 Aug 2020 |
| DOIs | |
| Publication status | Published - 15 Nov 2020 |
Keywords
- Adolescent
- Antibodies, Monoclonal, Humanized/therapeutic use
- Aspirin/therapeutic use
- Blood Coagulation Disorders/etiology
- C-Reactive Protein/analysis
- COVID-19/diagnosis
- Child
- Child, Preschool
- Female
- Fever/etiology
- Glucocorticoids/therapeutic use
- Humans
- Immunoglobulins, Intravenous/therapeutic use
- India/epidemiology
- Infant
- Intensive Care Units, Pediatric
- International Normalized Ratio
- Male
- Patient Admission/statistics & numerical data
- Platelet Aggregation Inhibitors/therapeutic use
- Prothrombin Time
- SARS-CoV-2
- Systemic Inflammatory Response Syndrome/diagnosis
Fingerprint
Dive into the research topics of 'Epidemiological and Clinical Profile of Pediatric Inflammatory Multisystem Syndrome - Temporally Associated with SARS-CoV-2 (PIMS-TS) in Indian Children'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver